Secretory leukocyte protease inhibitor reduces inflammation and alveolar bone resorption in LPS-induced periodontitis in rats and in MC3T3-E1 preosteoblasts |
| |
| Authors: | Seung-Yeon Lee Tae-Hee Nho Baik-Dong Choi Soon-Jeong Jeong Do-Seon Lim |
| |
| Institution: | 1. Department of Oral Histology &2. Developmental Biology, School of Dentistry, Chosun University, Gwangju, The Republic of Korea;3. Department of Dental Hygiene, College of Health Science, Youngsan University, Yangsan, The Republic of Korea;4. Department of Dental Hygiene, College of Health Science, Eulji University, Seongnam, The Republic of Korea |
| |
| Abstract: | In periodontitis, alveolar bone resorption is induced by excessive host immune and inflammatory response against bacterial infection. Secretory leukocyte protease inhibitor (SLPI) has anti-bacterial and anti-inflammatory activity in inflammatory responses. SLPI inhibits joint inflammation and bone destruction, but the function of SLPI in periodontitis is unclear. Therefore, this study investigated whether SLPI inhibits the inflammatory response and alveolar bone resorption in LPS-induced periodontitis of rats. Micro-computed tomography and histological analysis showed that SLPI inhibited alveolar bone resorption by LPS-induced periodontitis. Immunohistochemistry revealed that SLPI decreased tumor necrosis factor-α (TNF-α) and interleukine-1β (IL-1β) expression in periodontitis tissue, and decreased mRNA and protein expression of TNF-α and IL-1β in LPS-stimulated MC3T3-E1 cells. The results indicated that SLPI reduced alveolar bone resorption in LPS-induced periodontitis and inhibited inflammatory cytokine, such as TNF-α and IL-1β, expression in LPS-stimulated MC3T3-E1 preosteoblasts. Therefore, SLPI could be a regulatory molecule by inhibiting alveolar bone resorption through the reduction of inflammatory cytokines, and inducing osteoblast activation for bone formation. |
| |
| Keywords: | SLPI inflammation alveolar bone MC3T3-E1 periodontitis |
|
|
